Expression of retinoic acid receptors in human endometrial carcinoma

Cancer Science

Volumn 99, Issue 2, 2008, Pages 267-271

  Tanabe, Kojiro ^a   Utsunomiya, Hiroki ^a   Tamura, Mitsutoshi ^a   Niikura, Hitoshi ^a   Takano, Tadao ^a   Yoshinaga, Kohsuke ^a   Nagase, Satoru ^a   Suzuki, Takashi ^b   Ito, Kiyoshi ^a   Matsumoto, Mitsuyo ^a   Hayashi, Shin Ichi ^a   Yaegashi, Nobuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANTINEOPLASTIC AGENTS; BENZOATES; CARCINOMA; CELL PROLIFERATION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 38949175352     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00684.x     Document Type: Article

References (36)

1. Hong WK, Itri LM. Retinoids and human cancer. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry and Medicine, 2nd edn. New York: Raven Press, 1994; 597-630.
2. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278: 1073-7.
3. Nason-Burchenal K, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention. In: Bertino JR, ed. Molecular Biology of Cancer, 1st edn. San Diego: Academic Press, 1996; 1547-60.
4. Pfahl M, Piedrafita FJ. Retinoid targets for apoptosis induction. Oncogene 2003; 22: 9058-62.
5. Pitha-Rowe I, Petty WJ, Kitareewan S, Dmitrovsky E. Retinoid target genes in acute promyelocytic leukemia. Leukemia 2003; 17: 1723-30.
6. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1996; 46: 5-27.
7. Kohler MF, Nishi H, Humphrey PA et al. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol 1993; 169: 690-4.
8. Bo WJ, Smith MS. The effect of retinol and retinoic acid on the morphology of the rat uterus. Anat Rec 1996; 156: 5-9.
9. Boettger-Tong HL, Stancel GM. Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology 1995; 136: 2975-83.
10. Loughney AD, Kumarendran MK, Thomass EJ, Redfern CPF. Variation in the expression of cellular retinoid binding proteins in human endometrium throughout the menstrual cycle. Hum Reprod 1995; 10: 1297-304.
11. Kumarendran MK, Loughney AD, Prentice A, Thomas EJ, Redfern CP. Nuclear retinoid receptor expression in normal human endometrium throughout the menstrual cycle. Mol Hum Reprod 1996; 2: 123-9.
12. Siddiqui NA, Loughney A, Thomas EJ, Dunlop W, Redfern CPF. Cellular retinoid binding proteins and nuclear retinoic acid receptors in endometrial epithelial cells. Hum Reprod 1994; 9: 1410-16.
13. Arici A, Seli E, Senturk LM et al. Interleukin-8 in the human endometrium. J Clin Endocrinol Metab 1998; 83: 1783-7.
14. FIGO. Stages-1988 revision. Gynecol Oncol 1989; 35: 125-7.
15. Sasano H, Frost AR, Saitoh R et al. Aromatase and 17β-hydroxysteriod dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 1996; 81: 4042-6.
16. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605: 33-91.
17. Morriss-kay G. Retinoic acid receptors in normal growth and development. Cancer Surv 1992; 14: 181-93.
18. Lotan R, Xu XC, Lippman SM et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995; 332: 1405-10.
19. Xu XC, Sozzi G, Lee JS et al. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: Implications for lung cancer development. J Natl Cancer Inst 1997; 89: 624-9.
20. Picard E, Seguin C, Monhoven N et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 1999; 91: 989-91.
21. Castillo L, Milano G, Santini J, Demard F, Pierrefite V. Analysis of retinoic acid receptor β expression in normal and malignant laryngeal mucosa by a sensitive and routine applicable reverse transcription-polymerase chain reaction enzyme-linked immunosorbent assay method. Clin Cancer Res 1997; 3: 2137-42.
22. Widschwendter M, Berger J, Daxenbichler G et al. Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997; 57: 4158-61.
23. Qiu H, Zhang W, El-Naggar AK et al. Loss of retinoic acid receptor-β expression is an early event during esophageal carcinogenesis. Am J Pathol 1999; 155: 1519-23.
24. Berg WJ, Nanus DM, Leung A et al. Up-regulation of retinoic acid receptor β expression in renal cancers in vivo correlates with response to 13- cis -retinoic acid and interferon-α-2a. Clin Cancer Res 1999; 5: 1671-5.
25. Liu Y, Lee MO, Wang HG et al. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 1996; 16: 1138-49.
26. Lippman FR, Lee JJ, Karp DD et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001; 93: 605-18.
27. Khuri FR, Lee JJ, Lippman SM et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006; 98: 441-50.
28. Petty WJ, Li N, Biddle A et al. A novel retinoic acid receptor β isoform and retinoid resistance in lung carcinogenesis. J Natl Cancer Inst 2005; 97: 1645-51.
29. Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 1994; 54: 3580-7.
30. Sabichi AL, Xu X, Lippman SM. RARβ1′: Primed to fight retinoid resistance in lung carcinogenesis. J Natl Cancer Inst 2005; 97: 1632-3.
31. Pitha-Rowe I, Petty WJ, Feng Q et al. Microarray analyses uncover UBE1L as a candidate target gene for lung cancer chemoprevention. Cancer Res 2004; 64: 8109-15.
32. Freemantle SJ, Dragnev KH, Dmitrovsky E. The retinoic acid paradox in cancer chemoprevention. J Natl Cancer Inst 2006; 98: 426-7.
33. Loughney AD, Redfern CP. Menstrual cycle related differences in the proliferative responses of cultured human endometrial stromal cells to retinoic acid. J Reprod Fertil 1995; 105: 153-9.
34. Brar AK, Kessler CA, Meyer AJ, Cedars MI, Jikihara H. Retinoic acid suppresses in.vitro decidualization of human endometrial stromal cells. Mol Hum Reprod 1996; 2: 185-93.
35. Osteen KG, Keller NR, Feltus FA, Melner MH. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest 1999; 48 (Suppl 1): 2-13.
36. Ito K, Suzuki T, Moriya T et al. Retinoid receptors in the human endometrium and its disorders: A possible modulator of 17β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 2001; 86: 2721-7.